Jack R. Reifert
Jack R. Reifert publishes mostly in Molecular Biology, Oncology and Infectious Diseases, on topics such as Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research and Microtubule and mitosis dynamics.
- World rank
- #1,663,609 of 7,710,434 ranked researchers
- Rank in United States
- #515,569 of 1,627,098
- Works
- 32
- Citations
- 1.1k
- Citations per work
- 35.0
What does Jack R. Reifert research?
Jack R. Reifert's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (30%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1134.8%
- Medicine1134.8%
- Everything else1134.8%
- Life Sciences1030.4%
- 1Molecular Biology26% of their works
- 2Oncology15% of their works
- 3Infectious Diseases11% of their works
- 4Radiology, Nuclear Medicine and Imaging5% of their works
- 5Cell Biology4% of their works
- 6Rheumatology3% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- SARS-CoV-2 and COVID-19 Research
- Microtubule and mitosis dynamics
- Ubiquitin and proteasome pathways
- Wnt/β-catenin signaling in development and cancer
- vaccines and immunoinformatics approaches
- Viral gastroenteritis research and epidemiology
- Cancer Treatment and Pharmacology
Which keywords describe Jack R. Reifert's research?
The keywords of their largest research topics: Vaccine, Cancer Therapy, Fc Receptors, Therapeutic Antibodies, Coronavirus, SARS-CoV-2, Cell Division and Chemotherapy-Induced Peripheral Neuropathy.
- ß-Catenin
- Ubiquitin
- Rotavirus
- Peptide-MHC Binding
- Microtubules
- Chemotherapy-Induced Peripheral Neuropathy
- SARS-CoV-2
- Therapeutic Antibodies
- Cancer Therapy
- Vaccine
- Fc Receptors
- Coronavirus
- Cell Division
- Epitope Prediction
- Norovirus
- Proteasome
- Taxanes
- Wnt Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Vaccine72 topics
- Cancer Therapy62 topics
- Fc Receptors51 topic
- Therapeutic Antibodies51 topic
- Coronavirus41 topic
- SARS-CoV-241 topic
- Cell Division31 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Epitope Prediction31 topic
- Microtubules31 topic
- Norovirus31 topic
- Peptide-MHC Binding31 topic
- Proteasome31 topic
- Rotavirus31 topic
- Taxanes31 topic
- Ubiquitin31 topic
- Wnt Signaling31 topic
- ß-Catenin31 topic
Where does Jack R. Reifert work?
Jack R. Reifert's main affiliation in the publication record is Serimmune (United States), United States.
How many publications and citations does Jack R. Reifert have?
OpenAlex counts 32 works and 1,119 citations for Jack R. Reifert, an h-index of 15, ranking #1,663,609 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jack R. Reifert. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.